News and Announcements
Proteomics International (ASX: PIQ) Diabetic Kidney Disease Test Granted Patent in Russia
- Published December 19, 2016 3:55PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
19th December 2016 – ASX Announcement
Medtech company Proteomics International Laboratories (PILL) has been granted a patent in the Russian Federation for the company’s breakthrough diagnostic and prognostic test for diabetic kidney disease, “PromarkerD”.
By country, the Russian Federation has the fifth largest number of adults with diabetes (16.6 million) behind China, India, USA and Brazil, resulting in an estimated USD 14 billion in diabetes related health expenditures.
To view the full announcement please click on the button below.